Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021256-26-000008

Chief Financial Officer sold 36,371 shares at an average $28.17 ($1,024,719)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Setia Vishwas Chief Financial Officer 2026-05-04 Sale 10b5-1 −4,803 $27.36 $131,410 387,824 D
Setia Vishwas Chief Financial Officer 2026-05-04 Sale 10b5-1 −8,989 $28.28 $254,209 378,835 D
Setia Vishwas Chief Financial Officer 2026-05-04 Sale 10b5-1 −325 $29.56 $9,607 378,510 D
Setia Vishwas Chief Financial Officer 2026-05-04 Sale 10b5-1 −787 $30.12 $23,704 377,723 D
Setia Vishwas Chief Financial Officer 2026-05-05 Sale 10b5-1 −9,935 $28.12 $279,372 367,788 D
Setia Vishwas Chief Financial Officer 2026-05-05 Sale 10b5-1 −968 $29.00 $28,072 366,820 D
Setia Vishwas Chief Financial Officer 2026-05-06 Sale 10b5-1 −8,496 $28.04 $238,228 358,324 D
Setia Vishwas Chief Financial Officer 2026-05-06 Sale 10b5-1 −2,068 $29.07 $60,117 356,256 D
Open-market sales · 36,371 sh · avg $28.17 · $1,024,719
Loading xslF345X06/form4-05062026_080509.xml…